First use of intravenous artesunate in Liberia and effect on patient mortality relative to artemeter and quinine: a cross-sectional study

• Prif Awduron: Dr. Wilson Wang, MD (Awdur), Augustine Koryon, BS (Awdur), Bernice Dahn, MD (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Elsevier, 2014-05-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Background: Intravenous artesunate reduces mortality by 35% relative to intravenous quinine. In 2010, WHO changed guidelines favouring intravenous artesunate, yet wide-scale adoption lags. In April, 2012, the Clinton Foundation with the Liberian Health Ministry brought intravenous artesunate into Li...